Synergia Sciences

Synergia Life Sciences is a biotechnology company that specializes in the research, development, and manufacture of high-quality nutritional ingredients and probiotics. The company is best known for its flagship product, MenaquinGold, which is a natural Vitamin K2-7 produced through a proprietary fermentation process. In addition to Vitamin K2, Synergia offers a range of spore-forming probiotics, such as Bacillus subtilis HU58, which are designed for stability and efficacy in gut health applications. The company's products are backed by extensive clinical research and are used globally in dietary supplements and functional foods. In December 2021, Synergia was acquired by Novozymes (now Novonesis) for approximately $150 million to expand its human health portfolio. Today, it operates as a key innovation hub for advanced nutritional solutions within the larger corporate structure.